Back to MORGAN STANLEY MORGAN STANLEY

NRXPNRXP
9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in NRX PHARMACEUTICALS INC

MORGAN STANLEY holds 40,901 shares of NRXP (NRX PHARMACEUTICALS INC), worth $167,285 as of 2026-Q2. The position was increased (+307.9% shares).

Current Value

$167,285

Current Shares

40,901

Total Value Change

+$156,559

Total Shares Change

+36,505

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
40,901
+307.9%
$167,2850.0%$4.09
25
2026-Q1
Decreased
10,028
-0.0%
$21,3600.0%$1.80
0
2025-Q4
Decreased
10,029
-9.5%
$27,1790.0%$2.63
0
2025-Q3
Increased
11,080
+152.1%
$36,5640.0%$3.25
22
2025-Q2
Decreased
4,396
-63.0%
$14,3310.0%$3.42
0
2025-Q1
Increased
11,896
+170.6%
$24,3870.0%$2.03
21
2024-Q4
Unchanged
4,396
0.0%
$9,6710.0%$1.53
0
2024-Q3
Unchanged
4,396
0.0%
$7,4290.0%$1.75
0
2024-Q2
New
4,396
-
$10,7260.0%$2.44
26

Other major holders of NRXP: VANGUARD CAPITAL MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, BALYASNY ASSET MANAGEMENT L.P., CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used